Physician profile
Bryan Lawson
NPI 1629368527
$1,979.01
in general payments reported to CMS, 2019-2025
10 companies · $426 in 2025
The $426 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $551 · 2020: $129 · 2021: $153 · 2022: $421 · 2023: $58.04 · 2024: $241 · 2025: $426.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $725.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $724.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $413.29 | 2021-2024 | Cd Horizon Spinal System |
| Zimmer Biomet Holdings, INC. | $337.08 | 2019 | |
| Medtronic USA, INC. | $263.74 | 2019-2020 | |
| Orthofix Medical, INC. | $236.19 | 2024-2025 | Vu A-Pod Prime Nanometalene, 7d Surgical System |
| Nuvasive, INC. | $165.29 | 2022 | |
| Centinel Spine, LLC | $152.23 | 2025 | Prodisc L |
| Si-Bone, INC. | $145.59 | 2022 | |
| Globus Medical, INC. | $128.53 | 2025 | Harvest |
| Relievant Medsystems, INC. | $79.03 | 2019 | |
| Depuy Synthes Sales INC. | $58.04 | 2023 | Teligen |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bryan Lawson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.